Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Alvotech shares rose after the company said the Food and Drug Administration has approved a supplement to the biologics license application for AVT02 adalimumab-ryvk, marketed in the U.S. as Simlandi.